Health

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

PUBLISHED·3h ago·3 min read

GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough after mixed results showed limited efficacy in late-stage clinical studies.

Read the Full Story.

The Source

TWSJ

Business

On this beat

Health

How to Keep the Air Inside Safe From Wildfire Smoke

TNYT·1h ago·3 min read

Health

Level 2 – Chikungunya in Costa Rica

CDC·1d ago·3 min read

Health

World’s largest olive oil company says market has ‘definitively’ entered new phase

CNBC·11h ago·3 min read

Health

Some of the first at-home blood and saliva tests measuring the level of microplastics in our bodies are on the market. Your Health columnist Sumathi Reddy tried them out.

TWSJ·15h ago·3 min read

Read the Full Story.

TWSJ

Week Ahead for FX, Bonds: U.S., European PMI Data, ECB Decision in Focus

Lettuce Crisis Deals Blow to Taco Bell’s Fast-Food Stardom

‘Shanghai’ Review: Two Tales of the City

How Young Romance Overcomes Inflation: A $7 Coffee Date

On this beat

How to Keep the Air Inside Safe From Wildfire Smoke

Level 2 – Chikungunya in Costa Rica

World’s largest olive oil company says market has ‘definitively’ entered new phase

Some of the first at-home blood and saliva tests measuring the level of microplastics in our bodies are on the market. Your Health columnist Sumathi Reddy tried them out.